Robert Kneller

Title: The Innovations of Robert Kneller

Introduction

Robert Kneller is a notable inventor based in Tokyo, Japan. He is recognized for his contributions to the field of immunology, particularly in the development of vaccines. His innovative work has led to significant advancements in the fight against pneumococcal diseases.

Latest Patents

Robert Kneller holds a patent for a pneumococcal vaccine that combines selected alpha helical domains and proline-rich domains of pneumococcal surface protein A. This patent, which is a significant achievement in vaccine development, focuses on creating compositions and methods related to novel recombinant protein immunogens. The aHD-PRD constructs are designed to maximize cross-reactivity and provide protection against a broad spectrum of pneumococcal serotypes. The immunogenic compositions, including vaccines, may also include a non-linked aHD portion, enhancing their effectiveness.

Career Highlights

Throughout his career, Robert Kneller has worked with esteemed institutions such as the UAB Research Foundation and the University of Tokyo. His research has contributed to the understanding and development of immunological responses, particularly in relation to pneumococcal diseases.

Collaborations

Robert has collaborated with notable individuals in his field, including David E. Briles and Hiroshi Kiyono. These collaborations have further enriched his research and innovations in vaccine development.

Conclusion

Robert Kneller's work exemplifies the impact of innovative thinking in the field of immunology. His contributions, particularly in vaccine development, continue to play a crucial role in public health.